$300 Million for Type 1 Research: Congress Overrides Bush’s Veto of Medicare Bill

5844

July 16, 2008 – Congress was successful in overriding President Bush's veto of the Medicare legislation, including funding for diabetes research, that was passed by the House last month and by the Senate last week.

The legislation includes a two-year extension of the Special Diabetes Program (SDP), providing $300 million for type 1 diabetes research ($150 million per year for two years). This is the second largest influx of federal research dollars ever provided to fight this disease; a multi-year extension of the SDP was JDRF's top legislative priority this year. Passage of the bill avoids a 35 percent cut in federal support for type 1 diabetes research.

"This multi-year renewal of the SDP will enable NIH and the research community to continue aggressively fighting diabetes," said Larry Soler, JDRF's Vice President of Government Relations. "The strong bipartisan support for the SDP in Congress stems from its demonstrated record of success and return on the federal investment. JDRF is grateful and pleased that this Congress has made the future of this life-saving program a priority in a difficult budget climate."

Created in 1997, the SDP provides multi-year focused funding that has led to the development of new technologies and therapies that are helping people with diabetes and accelerating the pace of science leading to a cure. The SDP has been renewed by Congress four times and consists of two parts – research funding for type 1 diabetes and type 2 diabetes treatment and education programs for Native American populations.

Source: Juvenile Diabetes Research Foundation International

Comments

comments

This post authored by
Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.